These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3865651)

  • 1. Antilipolytic effects of N6-phenylisopropyladenosine and prostaglandin E2 in fat-cells of obese volunteers before and during energy restriction.
    Kather H; Wieland E; Fischer B; Schlierf G
    Biochem J; 1985 Nov; 231(3):531-5. PubMed ID: 3865651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antilipolytic action of insulin in abdominal adipocytes of obese subjects before and during energy restriction. Influence of adenosine deaminase.
    Kather H; Scheurer A; Schlierf G
    Int J Obes; 1987; 11(2):191-200. PubMed ID: 3301711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human fat cell lipolysis is primarily regulated by inhibitory modulators acting through distinct mechanisms.
    Kather H; Bieger W; Michel G; Aktories K; Jakobs KH
    J Clin Invest; 1985 Oct; 76(4):1559-65. PubMed ID: 2997284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the anti-lipolytic action and binding to plasma membranes of N6-L-phenylisopropyladenosine in adipocytes from starved and hypothyroid rats.
    Chohan P; Carpenter C; Saggerson ED
    Biochem J; 1984 Oct; 223(1):53-9. PubMed ID: 6497845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenergic regulation of lipolysis in abdominal adipocytes of obese subjects during caloric restriction: reversal of catecholamine action caused by relief of endogenous inhibition.
    Kather H; Wieland E; Fischer B; Wirth A; Schlierf G
    Eur J Clin Invest; 1985 Feb; 15(1):30-7. PubMed ID: 2859198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 action and binding in human adipocytes: effects of sex, age, and obesity.
    Richelsen B
    Metabolism; 1988 Mar; 37(3):268-75. PubMed ID: 3422703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet-activating protein discriminates the antilipolytic mechanism of insulin from that of other antilipolytic compounds.
    Kather H; Aktories K; Schulz G; Jakobs KH
    FEBS Lett; 1983 Sep; 161(1):149-52. PubMed ID: 6350045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A1-adenosine receptor-mediated inhibition of adipocyte adenylate cyclase and lipolysis in Zucker rats.
    Vannucci SJ; Klim CM; Martin LF; LaNoue KF
    Am J Physiol; 1989 Dec; 257(6 Pt 1):E871-8. PubMed ID: 2558574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adenosine on lipolysis in human subcutaneous fat cells.
    Ohisalo JJ
    J Clin Endocrinol Metab; 1981 Feb; 52(2):359-63. PubMed ID: 7462395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by cholera toxin of the antilipolytic action of prostanoids, N6-(phenylisopropyl) adenosine and insulin.
    Lambert B; Jacquemin C
    FEBS Lett; 1982 Jul; 143(2):188-92. PubMed ID: 6180930
    [No Abstract]   [Full Text] [Related]  

  • 11. Down-regulation of prostaglandin E receptors and homologous desensitization of isolated adipocytes.
    Robertson RP; Little SA
    Endocrinology; 1983 Nov; 113(5):1732-8. PubMed ID: 6138247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative studies of prostaglandin E2, phenylisopropyladenosine, clonidine and propranolol on lipolysis stimulated by methylisobutylxanthine and isoprenaline in hamster fat cells.
    Tan S; Curtis-Prior PB
    Prostaglandins Leukot Med; 1985 Feb; 17(2):183-90. PubMed ID: 2580319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of adipocyte lipolysis to stimulatory and inhibitory agonists in hypothyroidism and starvation.
    Saggerson ED
    Biochem J; 1986 Sep; 238(2):387-94. PubMed ID: 3026350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidic acid and phosphatidylinositol labelling in adipose tissue. The role of endogenously formed adenosine.
    Schimmel RJ; Honeyman TW; McMahon KK
    Biochem J; 1983 May; 212(2):499-506. PubMed ID: 6192808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antilipolytic effect of prostaglandin E2 in perifused rat adipocytes.
    Richelsen B; Pedersen SB
    Endocrinology; 1987 Oct; 121(4):1221-6. PubMed ID: 3308432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease of prostaglandin E2 receptor binding is accompanied by reduced antilipolytic effects of prostaglandin E2 in isolated rat adipocytes.
    Richelsen B; Beck-Nielsen H
    J Lipid Res; 1985 Jan; 26(1):127-34. PubMed ID: 2857758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antilipolytic action of insulin in adipocytes from starved and diabetic rats during adenosine-controlled incubations.
    Koopmans SJ; Sips HC; Bosman J; Radder JK; Krans HM
    Endocrinology; 1989 Dec; 125(6):3044-50. PubMed ID: 2684615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced binding and antilipolytic effect of prostaglandin E2 in adipocytes from patients with hyperthyroidism.
    Richelsen B; Pedersen O; Sørensen NS
    J Clin Endocrinol Metab; 1986 Feb; 62(2):258-62. PubMed ID: 3455691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased antilipolytic effect of the adenosine 'R-site' agonist N6-(phenylisopropyl)adenosine in adipocytes from adrenalectomized rats.
    Saggerson ED
    FEBS Lett; 1980 Jun; 115(1):127-8. PubMed ID: 7389912
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of adenosine deaminase, N6-phenylisopropyladenosine and hypothyroidism on the responsiveness of rat brown adipocytes to noradrenaline.
    Woodward JA; Saggerson ED
    Biochem J; 1986 Sep; 238(2):395-403. PubMed ID: 3800944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.